American Well Co. (NYSE:AMWL – Get Rating) CEO Ido Schoenberg sold 259,000 shares of the firm's stock in a transaction that occurred on Friday, September 9th. The shares were sold at an average price of $4.36, for a total value of $1,129,240.00. Following the completion of the transaction, the chief executive officer now owns 1,803,813 shares in the company, valued at approximately $7,864,624.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Ido Schoenberg also recently made the following trade(s):
Get American Well alerts:- On Monday, September 12th, Ido Schoenberg sold 50,943 shares of American Well stock. The shares were sold at an average price of $4.25, for a total value of $216,507.75.
- On Monday, August 1st, Ido Schoenberg sold 10,295 shares of American Well stock. The shares were sold at an average price of $4.03, for a total value of $41,488.85.
- On Friday, July 1st, Ido Schoenberg sold 300,000 shares of American Well stock. The shares were sold at an average price of $4.39, for a total value of $1,317,000.00.
- On Tuesday, June 21st, Ido Schoenberg sold 136,472 shares of American Well stock. The shares were sold at an average price of $4.61, for a total value of $629,135.92.
American Well Price Performance
AMWL stock traded down $0.22 during midday trading on Tuesday, hitting $4.03. 1,917,318 shares of the company's stock were exchanged, compared to its average volume of 2,536,481. The business has a 50-day simple moving average of $4.54 and a two-hundred day simple moving average of $4.04. American Well Co. has a 1-year low of $2.52 and a 1-year high of $11.40.
American Well (NYSE:AMWL – Get Rating) last posted its earnings results on Thursday, August 4th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.26) by $0.01. The company had revenue of $64.52 million during the quarter, compared to analysts' expectations of $64.13 million. American Well had a negative return on equity of 19.36% and a negative net margin of 90.47%. The firm's quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.15) earnings per share. As a group, research analysts anticipate that American Well Co. will post -0.99 earnings per share for the current year.Institutional Investors Weigh In On American Well
A number of institutional investors have recently modified their holdings of AMWL. Nisa Investment Advisors LLC grew its stake in shares of American Well by 440.0% in the first quarter. Nisa Investment Advisors LLC now owns 8,100 shares of the company's stock valued at $34,000 after buying an additional 6,600 shares in the last quarter. Point72 Hong Kong Ltd grew its stake in American Well by 175.1% during the 1st quarter. Point72 Hong Kong Ltd now owns 8,087 shares of the company's stock worth $34,000 after purchasing an additional 5,147 shares in the last quarter. Vigilant Capital Management LLC acquired a new position in American Well during the 1st quarter worth $42,000. US Bancorp DE grew its stake in American Well by 605.2% during the 2nd quarter. US Bancorp DE now owns 9,556 shares of the company's stock worth $42,000 after purchasing an additional 8,201 shares in the last quarter. Finally, Mackenzie Financial Corp acquired a new position in American Well during the 1st quarter worth $43,000. 46.62% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on the company. Piper Sandler decreased their target price on American Well from $6.00 to $5.00 in a research report on Wednesday, September 7th. Truist Financial started coverage on American Well in a research report on Wednesday, September 7th. They set a "hold" rating and a $5.00 price objective on the stock. Five equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, American Well has an average rating of "Moderate Buy" and an average target price of $8.50.
American Well Company Profile
(Get Rating)
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care.
Further Reading
- Get a free copy of the StockNews.com research report on American Well (AMWL)
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle's FQ1 Report
- Three Value Stocks For A Volatile Market
- 3 Energy Stocks Nearing Breakouts From Cup-Shaped Patterns
- Do These Dividend Achievers Deserve A Place In Your Portfolio?
Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.